Long-term outcome of (177)Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients

OBJECTIVE: Investigators have extensively explored the short-term safety and efficacy data on (177)Lu-PSMA-617 radioligand therapy (RLT) in mCRPC patients. However, scarce literature is reported on the long-term outcome of these patients. The current goal of this study is focused on the long-term ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Madhav Prasad, Ballal, Sanjana, Sahoo, Ranjit Kumar, Tripathi, Madhavi, Damle, Nishikant Avinash, Shamim, Shamim Ahmed, Kumar, Rakesh, Seth, Amlesh, Bal, Chandrasekhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109776/
https://www.ncbi.nlm.nih.gov/pubmed/33970962
http://dx.doi.org/10.1371/journal.pone.0251375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109776/
https://www.ncbi.nlm.nih.gov/pubmed/33970962
http://dx.doi.org/10.1371/journal.pone.0251375

Ejemplares similares